"Autoantibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
| Descriptor ID |
D001323
|
| MeSH Number(s) |
D12.776.124.486.485.114.323 D12.776.124.790.651.114.323 D12.776.377.715.548.114.323
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Autoantibodies".
Below are MeSH descriptors whose meaning is more specific than "Autoantibodies".
This graph shows the total number of publications written about "Autoantibodies" by people in this website by year, and whether "Autoantibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 3 | 1 | 4 |
| 2005 | 3 | 2 | 5 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 2 | 4 |
| 2010 | 2 | 3 | 5 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 4 | 5 |
| 2013 | 2 | 1 | 3 |
| 2014 | 1 | 1 | 2 |
| 2015 | 0 | 3 | 3 |
| 2016 | 5 | 2 | 7 |
| 2017 | 74 | 76 | 150 |
| 2018 | 74 | 51 | 125 |
| 2019 | 23 | 21 | 44 |
| 2020 | 7 | 12 | 19 |
| 2021 | 21 | 29 | 50 |
To return to the timeline, click here.
Below are the most recent publications written about "Autoantibodies" by people in Profiles.
-
Development of IgG, IgM, and IgA Autoantibodies Against Angiotensin Converting Enzyme 2 in Patients with COVID-19. J Appl Lab Med. 2022 01 05; 7(1):382-386.
-
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review. JAMA Cardiol. 2021 12 01; 6(12):1451-1460.
-
Development of ACE2 autoantibodies after SARS-CoV-2 infection. PLoS One. 2021; 16(9):e0257016.
-
Autoimmune complications of COVID-19. J Med Virol. 2022 01; 94(1):54-62.
-
No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021 09 30; 385(14):1334-1336.
-
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19. Sci Transl Med. 2021 09 22; 13(612):eabh2624.
-
Adaptive Immunity and the Risk of Autoreactivity in COVID-19. Int J Mol Sci. 2021 Aug 20; 22(16).
-
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021 08 19; 6(62).
-
COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors. Viruses. 2021 08 11; 13(8).
-
Autoantibodies stabilize neutrophil extracellular traps in COVID-19. JCI Insight. 2021 08 09; 6(15).